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Background: To investigate whether the number of subjects with severe hypoglycemia who are brought to a hospital emergency 
department is increasing and to identify whether there have been changes in the demographic and clinical characteristics of those 
subjects.
Methods: We analyzed data from the Emergency Departments of two general hospitals in Seoul, Korea. We included data from 
all adult subjects with type 2 diabetes who presented to an emergency department with severe hypoglycemia between January 1, 
2004 and December 30, 2009.
Results: A total of 740 cases of severe hypoglycemia were identified. The mean subject age was 69±12 years, mean duration of 
diabetes was 13.8±9.3 years, and 53.2% of subjects were receiving insulin therapy. We observed a sharp rise in the number of cas-
es between 2006 and 2007. Stages 3-5 chronic kidney disease was diagnosed in 31.5% of subjects, and low C-peptide levels (<0.6 
ng/mL) were found in 25.5%. The mean subject age, duration of diabetes, HbA1c level, and renal and insulin secretory function 
values did not change significantly during the study period. The proportion of glimepiride use increased, while use of gliclazide 
decreased among sulfonylurea users. Use of insulin analogues increased, while use of NPH/RI decreased among insulin users.
Conclusion: We identified a sharp increase in the number of subjects with severe hypoglycemia presenting to an emergency room 
since 2006. The clinical characteristics of these subjects did not change markedly during the study period. Nationwide studies are 
warranted to further clarify this epidemic of severe hypoglycemia.
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INTRODUCTION
The epidemic of diabetes mellitus is a worldwide problem, and 
Korea is no exception. While proper glucose control is a main-
stay for the prevention and management of diabetes-related 
complications, hypoglycemia remains a major problem associ-
ated with this disease [1-3]. Mild cases of hypoglycemia can be 
managed by the subject; however, severe hypoglycemia is ac-
companied by change in consciousness and can lead to trau-
ma, injury, and even death in rare cases [4].
  Since publication of results from the Diabetes Control and 
Complications Trial (DCCT) and the United Kingdom Pro-
spective Diabetes Study (UKPDS), glycemic control has been 
heavily emphasized in diabetes management for prevention of 
micro- and macrovascular complications [1,2]. However, it 
has been shown through recent landmark trials, such as Ac-
tion to Control Cardiovascular Risk in Diabetes (ACCORD), 
Action in Diabetes and Vascular Disease: Preterax and Diami-
cron MR Controlled Evaluation (ADVANCE), and Veterans 
Affairs Diabetes Trial (VADT), that intensive glycemic control 
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does not reduce mortality due to cardiovascular disease (CVD) 
in subjects with type 2 diabetes mellitus and may actually in-
crease CVD risk, especially in subjects with pre-existing coro-
nary heart disease (CHD) [5-7]. These trials have also shown 
that achieving rather aggressive HbA1c levels (<6.5%) is asso-
ciated with a three-fold increased risk of hypoglycemia.
  We recently noted that there might be a hypoglycemia epi-
demic in our community, as we were seeing more hypoglyce-
mic subjects admitted to hospitals via the emergency depart-
ment. We hypothesized that recent emphasis on glycemic con-
trol and changes in anti-diabetic medications may be influenc-
ing the incidence of severe hypoglycemia. 
  The aims of this study were to investigate whether the num-
ber of subjects with severe hypoglycemia presenting to an emer-
gency department has increased in recent years and to identify 
whether there were changes in the demographic and clinical 
characteristics of those subjects. We also aimed to investigate 
if there have been changes in sulfonylurea or insulin use in these 
subjects. 
METHODS
Research design and methods
Clinical data from the Emergency Departments of two general 
hospitals (Seoul National University Hospital and Eulji Uni-
versity Hospital) in Seoul were first obtained from the hospital 
databases. We included all adult subjects (aged ≥18 years) with 
type 2 diabetes mellitus who presented to the Emergency De-
partment with severe hypoglycemia between January 1, 2004 
and December 30, 2009. We searched for the following Inter-
national Classification of Diseases, Ninth Revision, Clinical 
Modification (ICD-9CM) codes to identify potential episodes 
of severe hypoglycemia: 1) hypoglycemic coma in diabetes mel-
litus (250.3); 2) hypoglycemic coma (251.0); 3) other specified 
hypoglycemia (251.1); 4) hypoglycemia, unspecified (251.2). 
We then had three medical doctors (J.T. Kim, T.J. Oh, Y.A. Lee) 
review the medical records of all subjects for validation of the 
events and to obtain data on related clinical factors. We only 
included subjects with severe hypoglycemia, defined as a se-
rum glucose level less than 60 mg/dL and the need for inter-
vention to recover from the hypoglycemic event [8]. 
  Using the subjects’ medical records, we obtained data on sex, 
age, height, weight, duration of diabetes, anti-diabetic treat-
ment, the inciting factor for hypoglycemia, alcohol consump-
tion, co-morbidities, and co-medications. In subjects taking 
both insulin and anti-diabetic medications, only insulin use 
was analyzed; for subjects taking multiple anti-diabetic oral 
medications, only sulfonylurea use was analyzed. The presence 
of diabetic macro- and microvascular complications were in-
vestigated. Data on HbA1c and fasting plasma C-peptide lev-
els, complete blood counts, serum chemistries, and random 
urine microalbumin/creatinine ratios were obtained. The most 
recent HbA1c data prior to the hypoglycemic episode was used 
for analysis. We used an abbreviated MDRD equation for esti-
mating glomerular filtration rate (GFR) [9], as follows: estima-
ted GFR (mL/min/1.73 m
2)=186×(creat/88.4)
-1.154×(age)
-0.203 
×(0.742, if female)×(1.210, if black). Stages 3-5 chronic kid-
ney disease (CKD) was defined when the eGFR was less than 
60 mL/min/1.73 m
2 [10]. A low C-peptide level was defined as 
that less than 0.6 ng/dL [11]. The institutional review board 
for each hospital approved the study protocol.
Statistical analysis 
All data are presented as mean±standard deviation. Group 
differences in means were tested by ANOVA or the Kruskall 
Wallis Test, as appropriate. Group differences in nominal vari-
ables were tested using the chi-square test. We analyzed trends 
over time using the chi-square test for linear trend and linear 
regression. Two-tailed P values <0.05 were considered statisti-
cally significant. Statistical analysis was conducted using com-
mercially available software (SPSS version 15.0; SPSS Inc., Chi-
cago, IL, USA).
RESULTS
A total of 740 cases of severe hypoglycemia were identified, and 
the clinical characteristics of the patients are presented in Ta-
ble 1. The mean subject age was 69±12 years old; 49.6% per-
cent of subjects were male; the mean duration of diabetes was 
13.8±9.3 years; mean body mass index was 23.2±3.8; and 53.2% 
of subjects were receiving insulin therapy. We noted a rather 
sharp increase in hypoglycemia cases in 2007 in both hospitals, 
and the level remained high for the remainder of the study pe-
riod (Table 2). The number of severe hypoglycemia cases in 
2009 (n=185) was 2.8-fold higher than the number in 2004 
(n=66) (Table 2). During the same period, the total number of 
subjects who visited the emergency rooms of these hospitals 
steadily increased by 1.4-fold (2004, n=54, 405; 2009, n=77, 
373) (Table 2). 
  Subjects visiting the emergency room due to severe hypo-168
Kim JT, et al.
Diabetes Metab J 2011;35:166-172 http://e-dmj.org
glycemia were more commonly in their seventies (n=287, 
38.8%), sixties (n=191, 25.8%), or eighties (n=121, 16.4%), in 
order of descending frequency (Fig. 1). When we divided the 
subjects into five groups according to age (≤50, 51-60, 61-70, 
71-80, and ≥81 years), there were no differences in duration of 
diabetes, HbA1c level, or serum creatinine level (Table 3). In-
sulin use and insulin secretory defects were more common in 
the younger age group, and stages 3-5 CKD was more com-
mon in the older age group (Table 3).
  The number of severe hypoglycemia cases increased consis-
tently in the two hospitals over the study period. Mean age, 
duration of diabetes, creatinine level, HbA1c level, insulin use, 
and C-peptide level did not change significantly during this 
period (Table 4). When we analyzed sulfonylurea and insulin 
use according to year of presentation, we found that the pro-
portion of glimepiride use increased, while gliclazide use de-
creased among oral drug users; and insulin glargine/detemir 
use increased, while insulin NPH/RI use decreased among in-
sulin users (Table 5). 
DISCUSSION
Hypoglycemia is the principal problem associated with strict 
glycemic control. Our study indicates that the number of sub-
jects with severe hypoglycemia requiring emergency depart-
ment visits has increased in recent years. Several previous epi-
demiologic studies have suggested that the incidence of severe 
hypoglycemia has also increased [12], while one study indicat-
ed that the increasing number may be due to the increased pre-
valence of type 2 diabetes mellitus, and that the rate of hypo-
Table 1. Clinical characteristics of the study subjects
Variable No. Value
Age, yr  740 69±12
Sex, M/F, n (%)  740 367 (49.6)/374 (51.4)
Duration of diabetes  463  12 (6-19)
BMI, kg/m
2 144 23.2±3.8
Insulin user, n (%) 613 326 (53.2)
HbA1c, % 498 7.2±1.6
Creatinine, mg/dL 639  1.1 (0.8-1.6)
S  tage 3-5 CKD (GFR<60 mL/min/ 
1.73 m
2), n (%)
639 233 (31.5)
C-peptide, ng/mL  376 1.5 (0.5-3.1)
D  ecreased C-peptide (<0.6 ng/dL),  
n (%)
376 96 (25.5)
Data are presented as either mean±standard deviation, median (IQR), 
or number (%). HbA1c level refers to the most recent test results pri-
or to the severe hypoglycemia episode.
BMI, body mass index; CKD, chronic kidney disease.
Table 2. Number of severe hypoglycemia events and Emergency Department visits
Year
E S Total
N(H) N(E) % N(H) N(E) % N(H) N(E) %
2004 14 30,711 0.46 52 23,694 2.19 66 54,405 1.21
2005 9 31,556 0.29 59 28,087 2.10 68 59,643 1.14
2006 19 32,927 0.58 45 30,164 1.49 64 63,091 1.01
2007 99 33,490 2.96 90 33,088 2.72 189 66,578 2.84
2008 85 36,860 2.31 83 34,645 2.40 168 71,505 2.35
2009 87 41,216 2.11 98 36,157 2.71 185 77,373 2.39
E, Eulji University Hospital; S, Seoul National University Hospital; N(H), number of severe hypoglycemia subjects; N(E), number of emergency 
department visits; %, proportion of severe hypoglycemia cases in Emergency Department visits. 
Fig. 1. Number of severe hypoglycemia subjects according to 
age.
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glycemia in the diabetic population has not changed [13]. The 
prevalence of type 2 diabetes mellitus in Korea has steadily in-
creased over the past 30 years; however, after the late 1990s, 
the maximum increase per year was estimated to be less than 
10% [14-16]. Accordingly, it is inferable from our data that the 
incidence of severe hypoglycemia in the diabetic population 
has also increased in Korea. 
  This trend is particularly problematic since it is prevalent 
among older adult subjects: those aged 60 years or older com-
prised the majority (83.2%) of the study population. It is con-
ceivable that severe hypoglycemia may occur more easily in 
older adult subjects with decreased cognitive function and ac-
Table 3. Comparison of clinical characteristics according to age
Age group,  
yr
Duration of diabetes,  
yr
HbA1c,  
%
Creatinine,  
mg/dL
Stages 3-5 CKD, 
no. (%)
Insulin user, 
no. (%)
Low C-peptide, 
no. (%)
<50 14 (7-16) 7.5±1.7 1.0 (0.7-1.8) 22 (55.0) 41 (89.1) 9 (37.5)
N 31 38 40 40 46 24
51-60 11 (5-18) 7.6±1.8 1.0 (0.8-1.5) 39 (52.0) 54 (70.1) 18 (40.0)
N 60 52 75 75 77 45
61-70 11 (7-17) 7.2±1.6 1.2 (0.9-1.9) 61 (38.1) 82 (52.9) 25 (27.8)
N 113 117 160 160 155 90
71-80 11 (5-20) 7.1±1.5 1.1 (0.8-1.5) 81 (31.9) 107 (45.3) 32 (20.4)
N 185 195 254 254 236 157
≥81 13 (8-22) 7.1±1.5 1.1 (0.8-1.4) 30 (27.3) 42 (42.4) 12 (20.0)
N 74 96 110 110 99 60
P value 0.611 0.074 0.210 <0.001 <0.001 0.038
Data are presented as either mean±standard deviation, median (IQR), or number (%). N is the total number of subjects with available data in 
each age group. Significance at P<0.05 according to ANOVA for duration of diabetes, HbA1c, and creatinine level. Significance at P<0.05 ac-
cording to chi-square test for stages 3-5 CKD, insulin user, and low C-peptide level. 
CKD, chronic kidney disease.
Table 4. Comparison of clinical characteristics according to year of presentation with severe hypoglycemia
Year  Age, yr  Duration of diabetes, yr HbA1c, %  Creatinine, mg/dL Insulin user, no. (%)  Low C-peptide, no. (%) 
2004 66.0±13.0 16 (7-20) 7.6±2.0 1.1 (0.9-1.7) 25 (67.6) 5 (19.2)
 N 66 27 45 58 37 26
2005 70.6±10.0 14 (6-17) 6.9±1.3 1.2 (0.9-1.7) 24 (42.9) 6 (19.4)
N  68 38 49 52 56 31
2006 69.9±12.5 10 (3-15) 7.2±1.1 1.1 (0.8-1.5) 25 (45.5) 10 (37.0)
N  64 38 49 52 55 27
2007 68.6±13.0 14 (8-20) 7.3±1.7 1.1 (0.8-1.6) 92 (57.9) 20 (20.2)
N  189 138 129 167 159 99
2008 69.6±10.9 10 (7-18) 7.1±1.5 1.1 (0.8-1.5) 83 (57.6) 21 (21.9)
N  168 111 102 147 144 96
2009 69.3±11.9 12 (6-20) 7.3±1.6 1.1 (0.8-1.5) 77 (53.2) 34 (35.1)
N  185 111 124 163 162 97
P value  0.295 0.185 0.850 0.845 0.511 0.053
Data are presented in either mean±standard deviation, median (IQR), or number (%). N is the number of total subjects with available data in 
each year. Significant at P<0.05 according to P for trend (linear by linear association) with regard to age, duration of diabetes, HbA1c, and cre-
atinine level. Significance at P<0.05 according to chi-square test for linear trend in insulin user and low C-peptide level. 170
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Table 5. Comparison of sulfonylurea and insulin use according to year of presentation with severe hypoglycemia
Year  Glimepiride Gliclazide Glibenclamide NPH/RI  Premixed Glargine/Detemir
2004  1/4 (25.0) 1/4 (25.0) 2/4 (50.0) 14/14 (100.0) 0/14 (0) 0/14 (0)
2005  9/16 (56.3) 4/16 (25.0) 3/16 (18.8) 11/12 (91.7) 1/12 (8.3) 0/12 (0)
2006  5/11 (45.5) 4/11 (36.4) 2/11 (18.2) 10/12 (83.3) 0/12 (0) 2/12 (16.7)
2007  21/31 (67.7) 2/31 (6.5) 8/31 (25.8) 32/53 (62.3) 9/53 (17.0) 12/53 (20.8)
2008  14/24 (58.3) 3/24 (12.5) 7/24 (29.2) 25/47 (53.2) 8/47 (17.0) 15/47 (29.8)
2009  22/27 (81.5) 2/27 (7.4) 3/27 (11.1) 22/47 (46.8) 15/47 (31.9) 10/47 (21.3)
P value  0.020 0.037 0.344 <0.001 0.001 0.013
Data are presented as number/total number (%). Total number is the number of total subjects with available data in each year. Significance at 
P<0.05 according to chi-square test for linear trend. 
tivity levels. In line with this finding, population-based studies 
in Scotland and Germany have demonstrated that severe hy-
poglycemia requiring emergency treatment is common among 
older adult subjects, and that age was a risk factor for severe 
hypoglycemia [17,18]. In contrast, a nationwide study in the 
Uinted States showed that the rate of severe hypoglycemia is 
higher in younger (age <45 years) and very old (age ≥75 years) 
subjects [13]. A cohort study in the United States also showed 
that older subjects experience a lower incidence of hypoglyce-
mia after investigating the frequency of severe hypoglycemia 
among subjects receiving insulin monotherapy [12]. One ex-
planation for the controversy is that age serves as a marker for 
the subject’s type of diabetes, with the proportion of type 2 di-
abetes mellitus subjects increasing with age. 
  Renal insufficiency was common among these subjects: 
31.5% of the study population had stages 3-5 CKD (GFR <60 
mL/min/1.73 m
2). A recent nationwide survey on diabetes 
complications in Korea showed that 30.3% of diabetics have 
microalbuminuria [19]. Insulin secretory defects were also 
common among these subjects; those with decreased C-pep-
tide levels (<0.6 ng/mL) made up 25.5% of the total popula-
tion. A study investigating C-peptide levels in a large number 
of Korean subjects with adult onset diabetes showed that 9.1% 
(922 of 10,172) had low C-peptide levels (<0.6 ng/mL) [20]. 
However, when we analyzed the clinical characteristics of our 
study subjects according to year of presentation, the increasing 
occurrence of severe hypoglycemia did not appear to be asso-
ciated with known risk factors, such as glycemic control status, 
duration of diabetes, age, renal function, or insulin secretory 
function. 
  The proportion of insulin users decreased during the study 
period. Use of insulin glargine and premixed insulin increased, 
while use of insulin NPH and RI decreased. Among sulfonyl-
urea users, the proportion of glimepiride users increased, while 
that of gliclazide users decreased. These changes in the use of 
sulfonylureas and insulin in hypoglycemia subjects may or may 
not be a reflection of changes in medication use due to the in-
troduction of newer-generation drugs. Further investigation 
into changes in medication use in the type 2 diabetes mellitus 
population may reveal an association between change in anti-
diabetic medication and incidence of hypoglycemia.
  Another interesting finding of our study was the sharp in-
crease in severe hypoglycemia after 2007. There is a need for a 
nationwide survey investigating if there have been changes in 
glycemic control status, anti-diabetic therapy, and diabetes ed-
ucation in type 2 diabetes mellitus subjects in recent years in 
order to draw any firm conclusion regarding the cause of this 
trend. Diabetes educators in Korea should recognize that the 
most common inciting cause of hypoglycemia reported by our 
study subjects was decreased or missed food intake. If HbA1c 
level goals are established, it is essential to educate the subjects 
about the potential risk of hypoglycemia and methods of avoid-
ing and treating it. 
  There are several limitations to this study. The major limita-
tion is that we collected data from only two hospitals located 
in the Korean capital city of Seoul. This limitation makes it dif-
ficult to extend the implications of our results throughout Ko-
rea and to other countries. Another limitation is the retrospec-
tive nature of our analysis. It is quite possible that data may 
have been missing from the subjects’ medical records, thus bi-
asing the results. Since some cases of severe hypoglycemia are 
treated effectively at home or work by friends, relatives, or col-
leagues, the results of the current study may not reflect the en-
tire sphere of severe hypoglycemia in our community. 171
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  In summary, we identified an increase in the number of se-
vere hypoglycemia subjects presenting to emergency rooms 
since 2004. Severe hypoglycemia prevails among older adults, 
and renal insufficiency and decreased endogenous insulin se-
cretion appear to be common conditions in these subjects. We 
also found that the use of newer generation sulfonylureas and 
insulin analogues increased during this period among our study 
subjects. A national survey is urgently needed to verify this 
epidemic and its implications.
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